down arrow

Medikit Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3921060004
JPY
2,967.00
-17 (-0.57%)

Mar 24

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
JEOL Ltd.
Jins Holdings, Inc.
Menicon Co., Ltd.
Medikit Co., Ltd.
Japan Lifeline Co., Ltd.
Fukuda Denshi Co., Ltd.
Mani, Inc.
Eiken Chemical Co., Ltd.
PHC Holdings Corp.
Hogy Medical Co., Ltd.
Takara Bio, Inc.

Why is Medikit Co., Ltd. ?

1
Company has very low debt and has enough cash to service the debt requirements
2
Poor long term growth as Net Sales has grown by an annual rate of 2.54% and Operating profit at 0.74% over the last 5 years
3
Flat results in Dec 25
  • INTEREST(9M) At JPY 5.74 MM has Grown at inf%
  • DEBT-EQUITY RATIO (HY) Highest at -47.44 %
  • CASH AND EQV(HY) Lowest at JPY 44,265.85 MM
4
With ROE of 6.67%, it has a very attractive valuation with a 0.87 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 10.92%, its profits have fallen by -0.3% ; the PEG ratio of the company is 1.1
5
Underperformed the market in the last 1 year
  • The stock has generated a return of 10.92% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 36.73%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Medikit Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Medikit Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Medikit Co., Ltd.
10.92%
0.16
16.39%
Japan Nikkei 225
36.73%
1.30
28.24%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
2.54%
EBIT Growth (5y)
0.74%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.51
Sales to Capital Employed (avg)
0.49
Tax Ratio
35.33%
Dividend Payout Ratio
44.00%
Pledged Shares
0
Institutional Holding
0.14%
ROCE (avg)
24.12%
ROE (avg)
6.42%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
0.87
EV to EBIT
3.65
EV to EBITDA
2.65
EV to Capital Employed
0.74
EV to Sales
0.73
PEG Ratio
1.06
Dividend Yield
NA
ROCE (Latest)
20.30%
ROE (Latest)
6.67%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
ROCE(HY)

Highest at 6.9%

RAW MATERIAL COST(Y)

Fallen by 0.69% (YoY

NET SALES(Q)

Highest at JPY 6,544.1 MM

OPERATING PROFIT(Q)

Highest at JPY 1,923.59 MM

PRE-TAX PROFIT(Q)

Highest at JPY 1,465.09 MM

-7What is not working for the Company
INTEREST(9M)

At JPY 5.74 MM has Grown at inf%

DEBT-EQUITY RATIO (HY)

Highest at -47.44 %

CASH AND EQV(HY)

Lowest at JPY 44,265.85 MM

Here's what is working for Medikit Co., Ltd.

Net Sales
Highest at JPY 6,544.1 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (JPY MM)

Operating Profit
Highest at JPY 1,923.59 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (JPY MM)

Pre-Tax Profit
Highest at JPY 1,465.09 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (JPY MM)

Raw Material Cost
Fallen by 0.69% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Medikit Co., Ltd.

Interest
At JPY 5.74 MM has Grown at inf%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Debt-Equity Ratio
Highest at -47.44 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Cash and Eqv
Lowest at JPY 44,265.85 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."